交易 | 地址 | 数量 |
---|---|---|
22b1fd...ed757d
|
the-void |
-
6.27960224 LTC
·
618.28 USD
|
22b1fd...ed757d
|
LhLXZR...g88aNn
|
+
6.27960224 LTC
·
618.28 USD
|
22b1fd...ed757d
|
script-a4f8a5b831416e6462e534c034306a56 |
+
0 LTC
·
0.00 USD
|
255ffa...6ec807
|
LVCGAZ...iVx1C4
|
-
0.52553549 LTC
·
51.74 USD
|
255ffa...6ec807
|
ltc1qh...ylt8jk
|
+
0.28 LTC
·
27.56 USD
|
255ffa...6ec807
|
LVCGAZ...iVx1C4
|
+
0.24440549 LTC
·
24.06 USD
|
255ffa...6ec807
|
the-void |
+
0.00113 LTC
·
0.11 USD
|
383371...bd6319
|
ltc1qu...f2p89k
|
-
0.297 LTC
·
29.24 USD
|
383371...bd6319
|
ltc1qk...2fdvt8
|
-
0.0402 LTC
·
3.95 USD
|
383371...bd6319
|
ltc1qx...xfkgcw
|
-
0.03807112 LTC
·
3.74 USD
|
MEI Pharma completes $100 million private placement to purchase Litecoin as reserve asset, first publicly traded company to do so.
LD Capital创始人JackYi分析认为,加密货币牛市具有轮动上涨规律,山寨币可能在最后补涨。
MEI Pharma's stock surged over 33%, raising its market cap to $41.24 million. A strategic transformation led by Titan Partners Group and GSR is pushing MEI Pharma to establish a Litecoin treasury strategy.